(Q38021373)

27 August 2017

title

Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug (English)

1 reference

27 August 2017

0 references

0 references

1 reference

7

Antonio Waldo Zuardi

1 reference

José Alexandre de Souza Crippa

27 August 2017

5

object named as

José Alexandre S Crippa

1 reference

27 August 2017

author name string

Alexandre Rafael de Mello Schier

1

1 reference

27 August 2017

Natalia Pinho de Oliveira Ribeiro

2

1 reference

27 August 2017

Adriana Cardoso de Oliveira e Silva

3

1 reference

27 August 2017

Jaime Eduardo Cecílio Hallak

4

1 reference

27 August 2017

Antonio E Nardi

6

1 reference

27 August 2017

publication date

1 June 2012

1 reference

Brazilian Journal of Psychiatry

27 August 2017

published in

1 reference

27 August 2017

volume

34 Suppl 1

1 reference

27 August 2017

page(s)

S104-10

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

27 August 2017

1 reference

Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Cannabis and anxiety: a critical review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Cannabidiol--recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Antianxiety effect of cannabidiol in the elevated plus-maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Agonistic properties of cannabidiol at 5-HT1a receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Anti-aversive effects of cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake Epicrates cenchria crassus confrontation paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Effects of cannabidiol (CBD) on regional cerebral blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsiv

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462012000500008

10.1590/S1516-44462012000500008

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference